Yi Liu

Title: Yi Liu - Innovator in Pharmaceutical Chemistry

Introduction

Yi Liu is a notable inventor based in Clark, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of receptor antagonists. His work has implications for the development of new therapeutic agents.

Latest Patents

Yi Liu holds a patent for the "Synthesis of CCR5 receptor antagonists." This invention focuses on the synthesis of a specific compound, 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], along with its intermediates. The synthesis is achieved from readily available starting materials through a novel route, showcasing Liu's innovative approach to chemical synthesis.

Career Highlights

Yi Liu is currently associated with Schering Corporation, where he continues to advance his research in pharmaceutical development. His work has led to the creation of valuable compounds that may contribute to future medical therapies.

Collaborations

Some of his notable coworkers include Xiongwei Shi and Man Zhu, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Yi Liu's contributions to the field of pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in therapeutic development.